© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Chris Mazzolini
Articles
FDA Clears First Plasma-Based Assay to Aid Alzheimer Disease Diagnosis
May 17, 2025
The diagnostic is designed to help clinicians determine the likelihood of cerebral β-amyloid plaque deposition, one of the neuropathologic hallmarks of AD.
Cervical Cancer Screening Best Practices for Physicians
May 09, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Understanding Gaps in Patient Knowledge of Cervical Cancer Screening
May 08, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Cervical Cancer Screening: What Physicians Can Do To Convince Patients
May 07, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Identifying HPV Types: Preventing Over Treatment and Under Treatment
May 06, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
BD Onclarity Added to ASCCP Guidelines: What It Means
May 05, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
The Role of Extended HPV Genotyping In Managing High Risk Patients
May 02, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Latest Guidelines and Best Practices on Cervical Cancer Screening
April 22, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences
Michael A. Weber, MD, on aprocitentan approval: A new approach to managing hypertension
March 21, 2024
Michael A. Weber, MD, an investigator in the PRECISION study, discusses the newly FDA approved drug aprocitentan (Tryvio), and its promise for helping patients with treatment-resistant hypertension.